Cargando…

A clinical perspective of obesity, metabolic syndrome and cardiovascular disease

The metabolic syndrome is a condition characterized by a special constellation of reversible major risk factors for cardiovascular disease and type 2 diabetes. The main, diagnostic, components are reduced HDL-cholesterol, raised triglycerides, blood pressure and fasting plasma glucose, all of which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Thang S, Lean, Mike EJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780070/ https://www.ncbi.nlm.nih.gov/pubmed/26998259 http://dx.doi.org/10.1177/2048004016633371

Ejemplares similares

Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome
por: Dandare, Abdullahi, et al.
Publicado: (2022)

Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications
por: Santos-Moreno, Pedro, et al.
Publicado: (2022)

Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea
por: Yang, Chung Shu, et al.
Publicado: (2017)

Metabolic syndrome and cardiovascular disease in South Asians
por: Eapen, Danny, et al.
Publicado: (2009)

Metabolic and Cardiovascular Implications of a Metabolically Healthy Obesity Phenotype
por: Seo, Mi Hae, et al.
Publicado: (2014)

Metabolic Syndrome and Cardiovascular Risk Factors in Obese Adolescent
por: Mansour, Manal, et al.
Publicado: (2016)

Iron Metabolism in Obesity and Metabolic Syndrome
por: González-Domínguez, Álvaro, et al.
Publicado: (2020)

From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2014)

Stress in Obesity and Associated Metabolic and Cardiovascular Disorders
por: Holvoet, Paul
Publicado: (2012)

YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease
por: Schernthaner, Gerit-Holger, et al.
Publicado: (2016)

Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective
por: Bozic, Josko, et al.
Publicado: (2021)

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
por: Nishiga, Masataka, et al.
Publicado: (2020)

Non-Traditional Cardiovascular Risk Factors in Adolescents with Obesity and Metabolic Syndrome May Predict Future Cardiovascular Disease
por: Tragomalou, Athanasia, et al.
Publicado: (2023)

Skeptical Look at the Clinical Implication of Metabolic Syndrome in Childhood Obesity
por: Wasniewska, Malgorzata, et al.
Publicado: (2023)

Obesity and Metabolic Syndrome in Korea
por: Oh, Sang Woo
Publicado: (2011)

Metabolic syndrome and cardiovascular risk
por: Alshehri, Abdullah M.
Publicado: (2010)

Relationship between the oral cavity and cardiovascular diseases and metabolic syndrome
por: Carramolino-Cuéllar, Esther, et al.
Publicado: (2014)

Obesity, Metabolic Syndrome, and Adipocytes
por: Dodson, M. V., et al.
Publicado: (2011)

Potential Cardiovascular and Metabolic Beneficial Effects of ω-3 PUFA in Male Obesity Secondary Hypogonadism Syndrome
por: Noce, Annalisa, et al.
Publicado: (2020)

Identification of Cardiovascular Risk Factors in Obese Adolescents With Metabolic Syndrome
por: Lee, Jung Won, et al.
Publicado: (2021)

A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma
por: Cauchy, François, et al.
Publicado: (2015)

Metabolic Syndrome, Chronic Kidney, and Cardiovascular Diseases: Role of Adipokines
por: Tesauro, Manfredi, et al.
Publicado: (2011)

Cardiovascular Changes Related to Metabolic Syndrome: Evidence in Obese Zucker Rats
por: Martinelli, Ilenia, et al.
Publicado: (2020)

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
por: Nikolic, Dragana, et al.
Publicado: (2013)

Zinc nanoparticles ameliorated obesity-induced cardiovascular disease: role of metabolic syndrome and iron overload
por: Bashandy, Samir A. E., et al.
Publicado: (2023)

Clinical Perspectives of Urocortin and Related Agents for the Treatment of Cardiovascular Disease
por: Ikeda, Keiichi, et al.
Publicado: (2012)

Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences
por: Hong, So-hyeon, et al.
Publicado: (2020)

Metabolic syndrome, obesity and kidney stones
por: Hess, Bernhard
Publicado: (2012)

Navigating data governance approvals to use routine health and social care data to evidence the hidden population with severe obesity: a case study from a clinical academic’s perspective
por: Williamson, Kath, et al.
Publicado: (2022)

The Role of Dietary Inflammatory Index in Cardiovascular Disease, Metabolic Syndrome and Mortality
por: Ruiz-Canela, Miguel, et al.
Publicado: (2016)

Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors
por: Romano, Alberto, et al.
Publicado: (2022)

Prevention of Diabetes and Cardiovascular Disease in Obesity
por: La Sala, Lucia, et al.
Publicado: (2020)

Cardiovascular and metabolic consequences of obesity
por: Head, Geoffrey A.
Publicado: (2015)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
por: Koyama, Hidenori, et al.
Publicado: (2007)

Metabolic syndrome and obesity in peritoneal dialysis
por: Lo, Wai Kei
Publicado: (2016)

Chronic Inflammation in Obesity and the Metabolic Syndrome
por: Monteiro, Rosário, et al.
Publicado: (2010)

Metabolic Syndrome, Obesity, and Gastrointestinal Cancer
por: Fujihara, Shintaro, et al.
Publicado: (2012)

Perspectives on Adipose Tissue, Chagas Disease and Implications for the Metabolic Syndrome
por: Nagajyothi, Fnu, et al.
Publicado: (2009)

Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective
por: Perco, Paul, et al.
Publicado: (2008)

The Metabolic Syndrome, Oxidative Stress, Environment, and Cardiovascular Disease: The Great Exploration
por: Hutcheson, Rebecca, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5sd70t8gmll780gf0skdp3gn90